Correlation Between 064058AH3 and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 064058AH3 and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 064058AH3 and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BK 47 and Abcellera Biologics, you can compare the effects of market volatilities on 064058AH3 and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 064058AH3 with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 064058AH3 and Abcellera Biologics.

Diversification Opportunities for 064058AH3 and Abcellera Biologics

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between 064058AH3 and Abcellera is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding BK 47 and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and 064058AH3 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BK 47 are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of 064058AH3 i.e., 064058AH3 and Abcellera Biologics go up and down completely randomly.

Pair Corralation between 064058AH3 and Abcellera Biologics

Assuming the 90 days trading horizon BK 47 is expected to under-perform the Abcellera Biologics. But the bond apears to be less risky and, when comparing its historical volatility, BK 47 is 15.99 times less risky than Abcellera Biologics. The bond trades about -0.1 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  273.00  in Abcellera Biologics on September 1, 2024 and sell it today you would earn a total of  28.00  from holding Abcellera Biologics or generate 10.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

BK 47  vs.  Abcellera Biologics

 Performance 
       Timeline  
064058AH3 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BK 47 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 064058AH3 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

064058AH3 and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 064058AH3 and Abcellera Biologics

The main advantage of trading using opposite 064058AH3 and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 064058AH3 position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind BK 47 and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal